How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Double Soft Tube Non-PVC Film Soft Bag Infusion Production Line Market
- By Bag Material Type: Non-PVC Film, PVC Film, Polyolefin Film, Ethylene Vinyl Acetate (EVA) Film, Polyester Film
- By Production Line Automation Level: Fully Automated, Semi-Automated, Manual Assembly
- By Bag Configuration: Double Soft Tube, Single Soft Tube, Multi-Chamber, Y-Type, T-Type
- By Application: Blood Infusion, Nutritional Infusion, Pharmaceutical Infusion, Chemotherapy Infusion, Dialysis Fluid
- By Production Capacity: Low Capacity (Below 1000 bags/day), Medium Capacity (1000-5000 bags/day), High Capacity (Above 5000 bags/day)
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Non-PVC Film leads By Bag Material Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 11 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 286 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.180 →
- 12 Company Profiles 11 players: SWOT & benchmarking p.188 →
Full report · locked preview
Everything inside the Double Soft Tube Non-PVC Film Soft Bag Infusion Production Line Market report
A complete, evidence-based study - 12 chapters and 120 sections covering market size, segmentation across 5 axes, regional analysis and 11 company profiles, forecast to 2033.
Segmentation covered
Companies profiled
★★★★★ Excellent
11 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →B. Braun Melsungen AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Fresenius Kabi
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Baxter International Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Terumo Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Nipro Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Ningbo David Medical Device Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →Jiangsu Yuyue Medical Equipment & Supply Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Shandong Weigao Group Medical Polymer Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Ningbo Tianan Medical Device Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Suzhou Medical Appliance Factory
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.209 →Shanghai MicroPort Medical (Group) Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.214 →Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Non-PVC Film51.8
- PVC Film12.6
- Polyolefin Film8.5
- Ethylene Vinyl Acetate (EVA) Film15.2
- Polyester Film12.0
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- B. Braun Melsungen AG21.1
- Fresenius Kabi11.5
- Baxter International Inc.9.1
- Terumo Corporation5.2
- Nipro Corporation14.0
- Ningbo David Medical Device Co. Ltd.11.1
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.5
- Europe21.9
- Asia Pacific19.9
- Latin America14.2
- Middle East and Africa9.4
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| B. Braun Melsungen AG | 81 | 76 | 93 | 80 | 90 | 81 | 84 |
| Fresenius Kabi | 78 | 69 | 81 | 76 | 72 | 81 | 76 |
| Baxter International Inc. | 78 | 81 | 76 | 72 | 84 | 75 | 78 |
| Terumo Corporation | 76 | 63 | 65 | 60 | 81 | 72 | 70 |
| Nipro Corporation | 76 | 56 | 77 | 54 | 77 | 58 | 66 |
| Ningbo David Medical Device Co. Ltd. | 64 | 59 | 53 | 58 | 64 | 59 | 60 |
| Jiangsu Yuyue Medical Equipment & Supply Co. Ltd. | 66 | 61 | 47 | 64 | 53 | 45 | 56 |
| Shandong Weigao Group Medical Polymer Co. Ltd. | 38 | 45 | 42 | 38 | 45 | 50 | 43 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- B. Braun Melsungen AG
- Fresenius Kabi
- Baxter International Inc.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| B. Braun Melsungen AG | ✓ | ◐ | ◐ | ✓ | ✓ | ✓ |
| Fresenius Kabi | ◐ | − | ✓ | ✓ | ◐ | ◐ |
| Baxter International Inc. | ✓ | ◐ | ✓ | ✓ | ✓ | ✓ |
| Terumo Corporation | ◐ | ◐ | ✓ | − | ✓ | − |
| Nipro Corporation | ◐ | − | ✓ | − | ◐ | ◐ |
| Ningbo David Medical Device Co. Ltd. | − | ◐ | − | − | − | − |
| Jiangsu Yuyue Medical Equipment & Supply Co. Ltd. | − | ◐ | − | − | ◐ | ◐ |
| Shandong Weigao Group Medical Polymer Co. Ltd. | − | − | − | − | ◐ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Challenger2
Strong scale, closing on the leaders.
Contender2
Focused players with pockets of strength.
Niche2
Specialists in a single segment or region.
Go-to-market strategy
Land Bag Material Type in North America, then scale across Double Soft Tube Non-PVC Film Soft Bag Infusion Production Line Market — a $331M beachhead inside a $5.69B market.
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Non-PVC Film
Best fit — highest urgency & budget in Bag Material Type.
PVC Film
Strong fit — clear ROI and a fast path to value.
Polyolefin Film
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Bag Material Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Production Line Automation Level & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Bag Configuration
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Positioning & messaging
§GTM 2 · p.194 →For Bag Material Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Double Soft Tube Non-PVC Film Soft Bag Infusion Production Line Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Investment thesis
Double Soft Tube Non-PVC Film Soft Bag Infusion Production Line Market is a resilient opportunity — $4.79B by 2033, compounding at 3.9%.
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →3.9% CAGR
Demand compounds through 2033, outpacing GDP across Bag Material Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Bag Material Type moving from early to mainstream — durable secular demand.
Consolidation upside
11+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →Return scenarios (2033 market value)
Fig. 6 · p.22 →Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Production Line Automation Level optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Double Soft Tube Non-PVC Film Soft Bag Infusion Production Line Market — a $4.14B market by 2033. Plan: grow share from 10.0% to 16.2%.
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 10.0% | 16.2% | On track |
| Revenue | $451M | $671M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 32.6% | 39.8% | On track |
| Customer retention | 84.8% | 94.1% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →Lead segment
Win in Bag Material Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
Adjacency
Build Production Line Automation Level capability
A defensible second engine — invest in Production Line Automation Level to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Bag Material Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Production Line Automation Level
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $99M capacity & capability investment
- Greenlight bolt-on M&A in Production Line Automation Level
- Authorise North America expansion plan
- Fund R&D program for Bag Material Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossOn track
- Input-cost & supply riskAhead
- Regulatory / policy changeBehind
- Execution & talentAt risk
Sales deck · value proposition
Win the Double Soft Tube Non-PVC Film Soft Bag Infusion Production Line Market conversation — a $4.51B market you can size, segment and defend in minutes.
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Bag Material Type
Goal Grow share in Bag Material Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →The business case (ROI)
Fig. 2 · p.9 →Why buyers trust it (proof points)
§1.3 · p.12 →Coverage includes
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Double Soft Tube Non-PVC Film Soft Bag Infusion Production Line Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
Your report is ready to access
Double Soft Tube Non-PVC Film Soft Bag Infusion Production Line Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Calcium Phosphates Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportCalcium glycinate Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportCoenzyme Q10 Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportClimbazole (CAS 38083-17-9) Market
Market size, share, segmentation and regional forecast.
$386M market · 2025 base year
View reportCleanroom Paint Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportCleanroom Paint and Primer Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportBioglass Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportCefuroxime Sodium API Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportCeftizoxime Sodium API Market
Market size, share, segmentation and regional forecast.
$641M market · 2025 base year
View reportCeftezole Sodium API Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportCefteram Pivoxil Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportCefprozil API Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy